Last updated: 2026-09-16 17:54:20. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Mannatech Inc. (MTEX) operates in the MEDICINAL CHEMICALS & BOTANICAL PRODUCTS sector and is listed on NASDAQ. The stock is currently priced at $8.03, with a market capitalisation of $15.44M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $3.80 to $12.45. This page covers its latest market performance, valuation, price trends and company information.
$15.44M | |
$8.10 | |
$261.00 | |
$3.14 | |
$8.20 | |
5.53K | |
25.55K | |
-- | |
$12.45 | |
$3.80 | |
-- | |
-- |
Mannatech Inc. (MTEX) is currently trading at $8.03 as of 2026-09-16 17:53:00, down 2.07% ($0.17) from the previous close of $8.20
During today's regular trading session, MTEX has traded between $3.14 and $261.00, with a trading volume of 5.53K shares. The current price is near the lower end of today's range.
Over the past seven days, Mannatech Inc. (MTEX) moved from $9.00 to $8.03, representing a decline of 10.83% ($0.97).
The stock traded between $7.40 and $9.65 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 83.76 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 48.8%
MTEX is currently trading at $8.03, placing it 48.8% of the way from its 52-week low of $3.80 to its 52-week high of $12.45. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from the Americas.
| Industry | MEDICINAL CHEMICALS & BOTANICAL PRODUCTS |
| Employees | 170 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Mannatech Inc. (MTEX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.